Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
UNICEF: More than 100 children killed in Gaza since ceasefire - 2Flu season is ramping up, and some experts are "pretty worried"
- 3Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
- 4Woman gives birth on roadside after hospital allegedly sent her home: Family
- 5Home Plan Tips for Seniors
- German foreign minister heads to China to talk rare-earth exports
- 6 Shades Brands For Seniors
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
- Benin coup thwarted by loyalist troops, president tells nation
- Vote in favor of Your Number one BWM Vehicles
- How grandchildren are stepping up to fill the caregiver gap
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- Forum Dvorah demands clear support for women in combat as IDF gender debate escalates
- Your guide to how to safely thaw and cook your Thanksgiving turkey this year, according to experts
